Inteins as Drug Targets and Therapeutic Tools is a research paper published in Frontiers in Molecular Biosciences (2022). On theSindex it has a DataRank of 0. It has been cited 19 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Division of Intramural Research, National Institute of Allergy and Infectious Diseases
Grant: AI161845 AI131669 AI140406 AI141178 AI140726
NIAID NIH HHS
Grant: R21 AI141178
NIAID NIH HHS
Grant: R01 AI161845
NIAID NIH HHS
Grant: R01 AI131669
NIAID NIH HHS
Grant: R01 AI140726
NIAID NIH HHS
Grant: R21 AI140406
National Institutes of Health
Grant: 5R01AI140726-04
High throughput screening of the Prp8 intein splicing inhibitors for pathogenic fungi
National Institutes of Health
Grant: 7R21AI141178-03
Discovery of therapeutics against Cryptococcosis by Repurposing Pharmaceutical Libraries
National Institutes of Health
Grant: 5R21AI140406-02
Neutralizing nanobodies as therapeutics for Dengue virus
National Institutes of Health
Grant: 5R01AI161845-02
High throughput screening assays to identify chemical probes targeting Hectd3, an E3 ubiquitin ligase implicated in multiple sclerosis
National Institutes of Health
Grant: 5R01AI131669-05
High throughput screening of orthosteric inhibitors of flavivirus protease
University of Arizona
Fields of Study
Keywords
Sustainable Development Goals